Nausea or vomiting occurs in 3 to 8 percent of GLP-1 trial participants, but the vast majority resolve without discontinuing therapy
doi: 10.1136/bmj.i4919 22
This study also highlighted a dose-dependent weight loss of up to 17%, significantly higher than the 3% loss observed with placebo [27]
Some of these compounds not only directly affect TC cells by reducing their viability, proliferation, or their ability to migrate to the metastatic side, but also indirectly affect cancer progression by regulating the secretion of pro-tumorigenic chemokines in the TC microenvironment
For high-quality, sterile injectable forms, patients can expect to pay on the higher end of the scale
At TrimRx, we simplify this process by offering a comprehensive service model